We previously showed that injury by partial duct ligation (PDL) in adult mouse pancreas activates Neurogenin 3 (Ngn3) þ progenitor cells that can differentiate to b cells ex vivo. Here we evaluate the role of Ngn3 þ cells in b cell expansion in situ. PDL not only induced doubling of the b cell volume but also increased the total number of islets. b cells proliferated without extended delay (the so-called 'refractory' period), their proliferation potential was highest in small islets, and 86% of the b cell expansion was attributable to proliferation of pre-existing b cells. At sufficiently high Ngn3 expression level, upto 14% of all b cells and 40% of small islet b cells derived from non-b cells. Moreover, b cell proliferation was blunted by a selective ablation of Ngn3 þ cells but not by conditional knockout of Ngn3 in pre-existing b cells supporting a key role for Ngn3 þ insulin À cells in b cell proliferation and expansion. We conclude that Ngn3 þ cell-dependent proliferation of pre-existing and newly-formed b cells as well as reprogramming of non-b cells contribute to in vivo b cell expansion in the injured pancreas of adult mice.
Subject Category: Experimental Medicine
Adult non-b cells do not form new b cells during normal postnatal development or pregnancy, nor following partial pancreatectomy or partial b cell ablation. [1] [2] [3] Pre-existing b cells are thus a major source of new b cells under normal physiological conditions and following relatively mild injury in postnatal pancreas. [1] [2] [3] The replication potential of these cells is homogeneous 4 and limited by an extended delay or 'refractory period'. 3, 5 We showed that severe injury caused by partial duct ligation (PDL) in adult mouse pancreas activates a population of embryonic-type endocrine progenitor cells. 6 Expression of the earliest crucial transcription factor for embryogenesis of the endocrine pancreas, Neurogenin 3 (Ngn3), [7] [8] [9] was strongly activated in PDL pancreas specifically in cells near the lining of ducts. 6 These Ngn3 þ cells did not derive from hormone þ cells and did not proliferate but, when isolated and grafted in explanted embryonic pancreas, differentiated towards functional b cells with elevated cell cycle activity. 6 Although insulin content and absolute b cell mass increased in the ligated part of PDL pancreas 6, 10 it remains unclear whether adult Ngn3 þ non-b cells contribute to b cell formation in vivo. For instance, exocrine-to-b cell transition in PDL pancreas has been confirmed by some 11 but contradicted by other reports. [12] [13] [14] [15] The present study on b cell dynamics in PDL pancreas by tracing of Ngn3 þ cells, pre-existing b cells, and on b cell proliferation shows that b cell neogenesis does occur in the PDL pancreas and that proliferation of both pre-existing and newly formed b cells increases the b cell volume in vivo.
Results
Partial duct ligation generated b cell volume, new islets and b cells prone to redivide. PDL surgery caused doubling of b cell mass in murine pancreas in some 6, 10 but not in other studies. 12, 15 Differences in tissue density between normal and duct ligated pancreas have been suggested to introduce a bias in b cell mass measurements, 12 therefore we determined b cell volume in the ductligated part of pancreas (from hereon called PDL tail) as compared with Sham-operated control pancreas (Sham tail) of Balb-c mice. Throughout this study surgery was performed on male mice of 8 weeks. b cell volume and islet size distribution were quantified by immunofluorescence in a semi-automated manner on 4 mm thick sections, 36 mm apart and spanning the whole tissue, corresponding to the analysis of 10% of the total volume of day 14 PDL-and Sham tail. The total b cell volume in PDL tail increased twofold as compared to Sham tail (Figure 1a ). The total number of islets was increased more than twofold, specifically among the small b cell clusters (12-50 mm diameter; B1-10 insulin þ cells on cross-section) ( Figure 1b ). Analysis of independent samples by automated whole-tissue optical projection tomography (OPT) [16] [17] [18] also indicated PDL-induced increase of total b cell volume and islet number (Figure 1c ).
To study the mechanism behind this b cell expansion we first examined b cell proliferation. From hereon, quantifications were done by inspection of individual cells, in a non-automated manner. In PDL tail the percentage of insulin þ cells containing the proliferation marker Ki67 was increased above the normal physiological level in Sham tail or in the unligated part of PDL pancreas (termed PDL head) ( Figure 1d ). The percentage of b cells copositive for the b cellspecific transcription factor Nkx6.1 and for Ki67 was likewise increased (Figure 1e The total islet volume increased after PDL to 2.0 Â 10 9 ±3.5 Â 10 8 mm 3 (compared with Sham tail 1.1 Â 10 9 ±2.8 Â 10 8 mm 3 ; n ¼ 3; P ¼ 0.056). The total number of insulin þ islets significantly increased from 1000±184 in Sham to 1539±77 in PDL tails (n ¼ 3; Po0.05). This increase could be attributed to a significant increase in small islets (o10 6 mm 3 ) (711±107 islets in Sham versus 1082±25 islets in PDL; n ¼ 3; Po0.05). (d,e) b cell proliferation was determined in ligated PDL tail, unligated PDL head or Sham tail pancreas, at 7 and 14 days post-PDL by immunofluorescence staining (d) for insulin and Ki67 (n ¼ [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] or (e) for insulin, Nkx6.1 and Ki67 (n ¼ 3) (***Po0.001, ns: P40.05, versus Sham tail or PDL head by two-way ANOVA). (f) 5-iodo-2 0 -deoxyuridine (IdU, 1 mg/ml) was i.p. injected precisely at 8 and 4 h before sacrifice at the indicated time points following PDL. The percentage of IdU-labeled b cells was determined by immunostaining for insulin and IdU (n ¼ 3, *Po0.05, **Po0.01 versus Sham tail by two-way ANOVA). 1800 ± 200 b cells were counted per tissue sample. See also Supplementary Figure S4A b-cell neogenesis and proliferation in PDL pancreas M Van de Casteele et al and 4 h before sacrifice, b cell labeling was significantly higher in PDL tail than in Sham tail at days 7 and 14 following surgery ( Figure 1f ). In (re)generation models studied so far very few b cells go through multiple cell cycles. 3 Labeling mice first with the thymidine analog 5-chloro-2 0 -deoxyuridine (CldU) and then with IdU allows tracing cells that have undergone one or more rounds of division in vivo. 3 To minimize the risk of misinterpretation of data we used the published antibodies for specific detection of either CldU or IdU, 3 verified whether these antisera reacted specifically with either analog in PDL pancreas and found no cross-reactivity ( Supplementary  Figures S1A and B) . Second, CldU-and IdU-labeled cells were detected using fluorescent probes Cy5 and Cy2, respectively, which have minimal overlap in excitation/emission spectra ( Supplementary Figures S1C and D) .
As control experiment, double labeling of b cells was evaluated in neonatal Balb-c mice that received i.p. CldU on day 5 (P5) and i.p. IdU on P6. This resulted in high numbers of CldU-single positive and IdU-single positive b cells, but only very few doubly labeled b cells (Figure 2a and Supplementary Figure S2A ). These data closely match the (re)-replication rates for neonatal b cells previously published by others 3 and support their general conclusion that b cells are virtually always labeled with CldU or IdU, but rarely both. 3 Figure 2a ) and other models (Figure 2e ). This indicated that part of the b cells in PDL tail redivided more often than theoretically expected from stochastic kinetics, representing a subpopulation of b cells in PDL tail that preferentially cycle. 
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Neonatal (this study) Continuous thymidine analog labeling during 7, 14 or 35 days showed long-term subsistence of a higher proliferation potential by b cells in small clusters of 1-20 insulin þ cells in PDL tail (Figures 3a-c, respectively). At 35 days post-PDL the majority of clusters with r20 insulin þ cells consisted entirely of insulin þ cells that had divided (Figure 3d ), indicating that the majority of small islets are generated through replication. In addition, consecutive labeling with CldU and IdU showed that the rate of redivision by b cells in PDL tail was highest in small clusters ( Figure 3e ). IdU pulse labeling indicated different proliferation kinetics in small and large (21-200 insulin þ cells) clusters of PDL tail, but no changes in the corresponding b cell populations of Sham tail (Figure 3f ). These results assign small islets as the preferential site for b cell (re)division. On the basis of the IdU pulse label and volumetric assay of b cells in PDL and Sham tail pancreas, the b cell growth was mathematically modeled. The calculations suggested that proliferation of pre-existing b cells can account for 86% of the b cell expansion observed in PDL tail (Supplementary Figure  S4A ) and that small clusters present at day 7 of PDL can expand their b cell numbers nearly threefold in the second week of PDL to generate larger clusters (Supplementary Figure S4B ). 19, 20 were generated to evaluate possible contribution of progenitors to b cell growth by permanent tracing of cells with activated Ngn3 and descendants thereof. These cells constitutively express the reporter protein YFP once the stop sequence that prevents reporter gene expression is removed (Figure 4a ) upon treatment of mice with tamoxifen (TAM). Male Ngn3 CreER-T;R26YFP mice of 8 weeks underwent PDL surgery, were subcutaneously injected with TAM and were sacrificed at day 14 post-PDL ( Figure 4a ). As Ngn3 progenitors could be activated at any time-point following PDL and the Ngn3 promoter activity in these cells is transient, 6, 9 repeated injections of tamoxifen were applied (starting at the day of surgery: s.c. injection of 4 mg, repeated once-every-other-day, five injections in total) for maximizing the number of labeled progenitors (Figure 4a ). YFP was expressed in enteroendocrine cells of duodenum (Supplementary Figure S5A ), in cytokeratin19 þ (CK19 þ ) and insulin þ (INS þ ) cells located along the duct lining ( Supplementary Figures S5B and C) , and in small clusters of CK19 þ INS þ cells associated with ducts ( Figure 4b ). The fraction of YFP þ b cells in islets (Figure 4c , Supplementary Figure S5D ) increased with Ngn3 transcript level in PDL tail but not in PDL head (Figure 4d ). These results suggest that the contribution of Ngn3 þ cells to b-cell neogenesis correlates to the level of Ngn3 gene expression following injury. In PDL tails with a Ngn3 transcript level above 60% of duodenum, 39.4±3.2% of b cells were YFP þ in small versus 15.4±1.1% in large clusters, at day 35 post-PDL ( Figure 4e ). In PDL head, no such difference was found (0.6 ± 0.6% YFP labeling of b cells in small clusters versus 1.49±0.16% in large clusters, P40.05, n ¼ 9). Labeling mice with the thymidine analog IdU via the drinking water indicated that a large fraction of YFP þ b cells in PDL tail pancreas was involved in proliferation and that YFP þ insulin þ cells proliferated more in small than in large b cell clusters (Figure 4f ).
Clusters of 1-20 beta cells
New b cells dilute pre-existing b cells in PDL islets. To investigate whether in PDL pancreas b cells can also derive from non-b cells, the ratio between pre-existing and newly formed b cells was investigated in RIP CreERT ;R26 LacZ mice 1 (Figure 5a ). Following TAM-treatment, washout and PDL surgery, mice were sacrificed after a 14 or 35 days chase period (Figure 5a ). PDL tails with high Ngn3 mRNA (460% of duodenum transcript level) were analyzed for the presence of bGal þ b cells and compared with PDL head of the same pancreas. In PDL head 82 ± 5% of b cells (6720 INS þ cells counted in three mice) expressed bGal, representing the labeling efficiency at day 14 post-PDL (Figure 5b ). In PDL tail of the same mice, 74 ± 6% of all b cells (8216 insulin þ cells counted) was bGal þ (Figure 5b ). During 14 days following surgery pre-existing b cells had been diluted by unlabeled newly formed b cells in small islets of PDL tail only (Figure 5b ). An extended post-PDL chase period of 35 days resulted in a statistically significant decrease (70 ± 4% versus 82.5 ± 0.3%) in preponderance of bGal þ b cells in PDL tail (14510 INS þ cells counted in three mice) as compared with PDL head (13544 INS þ cells counted) (Figure 5c ). The dilution of labeled cells indicated that up to 14.6% of all b cells and 42% of b cells in small islets in PDL tail derived from non-b cells (Supplementary Figure S4C) . The preponderance of bGal þ b cells at day 35 was significantly decreased in islets of various sizes in PDL tail (Figure 5c ). Remarkable were islets that consisted nearly entirely of bGal À insulin þ cells (Figure 5d , Supplementary Figure S6 ) whereas bGal þ insulin þ cells predominated in islets of PDL head of the same mice (Figure 5e, Supplementary Figure S6 ). With an average of 70% bGal þ b cells in PDL tail (Figure 5c ), binomial probability calculation results in a chance of 5.4 Â 10 À 7 for any islet with 20 b cells of having only three or less bGal þ b cells. In reality, 12 out of 186 islets with 20-200 b cells ( ¼ 6.4 Â 10 À 2 ) were found with three or less bGal þ b cells in PDL tail. In PDL head of these mice, no such islets were observed (276 large islets inspected). This finding excludes that these islets with strongly diluted label arose by chance. Similar results were obtained in independent experiments using RIP CreERT ;R26 YFP mice 20, 21 (Supplementary Figure S7) . The active dilution of pre-existing labeled b cells in PDL tail supports a process of b cell neogenesis from non-b cells.
Ngn3 þ non-b cells are required for b cell formation in PDL pancreas. Above results suggested that expansion of the b cell mass in PDL pancreas correlates with activation of Ngn3 gene expression and occurs by proliferation of both preexisting and newly formed b cells. To address the role of Ngn3 þ cells in b cell expansion, the effect of their selective ablation was studied. Ngn3 CreERT ;R26 iDTR mice were generated to constitutively express simian diphtheria toxin receptor (DTR) following removal of a transcriptional STOP cassette 22 by inducible CreERT recombinase whose expression is controlled by the Ngn3 promoter. 19 Administration of diphtheria toxin (DT) to R26 iDTR þ / þ mice specifically and efficiently kills cells that have undergone Cre-mediated deletion of the STOP sequence. 22 PDL surgery and TAM administration to
iDTR þ / þ control littermates was followed by i.v. injection of DT (Figure 6a ). On the basis of the Ngn3 transcript level, 77% of Ngn3 þ enteroendocrine progenitor cells in duodenum and 66% of Ngn3 þ cells in PDL tail could be ablated (Figure 6b ), resulting in 28% decrease in insulin content (Figure 6c ). In Figure 6e ), suggesting complete dependence on Ngn3 þ cells. DT treatment of Ngn3 CreERT À / þ ;R26 iDTR þ / þ , Sham operated mice showed no effect on insulin content, nor on b cell proliferation (Supplementary Figure S8 ). Together the results indicate that Ngn3 þ cells are required for the expansion of b cells in PDL pancreas, while in normal pancreas Ngn3 þ cells do not contribute to the generation of b cells. To address whether the expression of Ngn3 in pre-existing b cells have a role in b cell expansion following PDL, the Ngn3 gene was conditionally inactivated in mature b cells of RIP CreERT ;Ngn3 lox/lox mice 1, 19 before PDL surgery. Fiveweek-old mice were TAM-injected followed by a washout period, and PDL surgery was performed at week 8 of age. At day 14 postsurgery, the b cell proliferation rate in PDL tail of pancreas in RIP CreERT ;Ngn3 lox/lox mice was not different from that in RIP CreERT ;Ngn3 þ / þ mice (Figure 6f ). The efficiency of Ngn3 inactivation in b cells, was evaluated in RIP CreERT ;R26 YFP ;Ngn3 þ /lox mice that had received TAM as before. After islet isolation and dissociation, islet cells were sorted on basis of TSQ (TSQ high marks endocrine cells 6 ) and YFP fluorescence, which showed that 79 ± 1% (n ¼ 4) of TSQ high islet cells were also YFP þ , representing b cells with Cre activation. Moreover, amplification of DNA extracted from YFP þ b cells using Ngn3 lox -specific primers revealed that these cells had completely lost their Ngn3 lox allele in contrast to the YFP À islet cells (Figure 6g ). Together, the data suggest that deletion of Ngn3 in pre-existing b cells occurred very efficiently, and that Ngn3 in non-b and newly formed b cells rather than in pre-existing b cells was required for b cell proliferation and expansion observed in PDL pancreas.
Discussion
Our previous findings indicated that upon PDL surgery b cells expand and Ngn3 þ endocrine progenitors are activated. 6 In the present study, we examined relative contributions of neogenesis and proliferation to the expansion of b cells. For evaluation of the impact by proliferation of pre-existing b cells, three parameters were determined: b cell expansion, proliferation rates, and the mode of b cell replication. Total b cell volume doubled and b cells proliferated more in PDL tail pancreas without restriction to re-engage in cycling. Modeling b cell proliferation according to these parameters suggests that 86% of b cells in PDL tail pancreas at 14 days postsurgery derive from pre-existing ones. Dilution of permanently labeled pre-existing b cells 1 indicated that 14.6% of the total b cell population derived from non-b cells. PDL increased the total number of islets and in particular the number of small islets where 42% of b cells derived from a non-b cell origin and the b cell cycling activity was high. The small islets can give rise to larger ones within 14 days. The majority of small clusters were composed entirely of dividing b cells and there was evidence for large clusters of 420 b cells on cross-section that consisted nearly entirely of new b cells, while no such islets were found in the unligated part of PDL pancreas. Taken together, our findings show that both neoformation and proliferation of b cells contribute to the b cell expansion in adult PDL pancreas. We confirm previous findings 4 that in adult normal pancreas b cells in different islets appear to have an equal potential for growth but show that this is not the case in PDL pancreas where small islets are foci for b cell (re)replication and neogenesis. The possibility to trigger the formation of islets with replication-prone b cells opens a new perspective for regenerative strategies.
Permanent genetic tracing of cells that activated Ngn3 gene expression detected up to 40% of label þ b cells in small clusters in PDL. Similar fractions of newly formed label À b cells were observed by b cell tracing in PDL pancreas suggesting that the Ngn3 þ cells were newly formed b cells. Although Ngn3 expression has also been reported in mature b cells of normal pancreas, 19 we found only few label þ b cells in Sham tail and PDL head pancreas of Ngn3 þ cell tracer mice. Moreover, conditional ablation of Ngn3 þ cells had no effect on the insulin content or b cell proliferation in PDL head or Sham tail pancreas, suggesting either no influence of Ngn3 þ b cells on these parameters or a too low expression level of Ngn3 in b cells to cause Cre-induced recombination. In contrast, DT-ablation of part of the Ngn3 þ cells in PDL tail reduced both insulin content and b cell proliferation. This corroborates our previous finding that knockdown of Ngn3 in PDL pancreas reduces b cell proliferation and mass expansion. 6 Thus, unlike in adult normal pancreas, b cell expansion in PDL depends on Ngn3 þ cells. Inactivation of the Ngn3 gene in pre-existing b cells does not affect b cell proliferation in PDL tail pancreas suggesting that Ngn3 þ non-b cells or newly formed b cells are important for stimulating proliferation as the main mechanism of b cell expansion in PDL pancreas. We cannot presently exclude that b cells under these conditions are more stressed than in normal conditions, which may enhance b cell expression of Ngn3 23 and dedifferentiation to progenitor-like Ngn3 þ cells. 24 We have not observed increased activation of caspase-3 in PDL b cells ( 6 and unpublished results), and b cells isolated from PDL pancreas did not show decreased Foxo1, Ins1 or Ins2 mRNA expression (unpublished data), which seems to argue against dedifferentiation under stress. Nevertheless, this requires more investigation. As only a small proportion of all b cells derived from Ngn3 þ cells but 53% of b cell proliferation was prevented by ablation of the Ngn3 þ cells, our data suggest Our finding of newly-formed but also preexisting b cells with high cycling activity within small clusters suggests that the microenvironment of small islets in PDL have a role in enhanced recruitment of b cells into cycling.
The inconsistent outcome of PDL in terms of b-cell neogenesis [12] [13] [14] in recent studies may be explained by differences in activation of Ngn3 gene expression. Our data suggest b-cell neogenesis to correlate with Ngn3 gene expression following PDL, arguing in favor of a threshold below which reprogramming will not be stimulated -a principle that has been described before 25 -and providing us with a way to screen for conditions and drugs favoring this process. In view of our present data, relatively poor activation of Ngn3 gene expression in PDL pancreas as reported by some 12, 13 is an unfavorable condition for b-cell neogenesis. On the other hand, our present data on Ngn3 tracing and dilution of pre-existing b cells indicate that direct derivation of b cells from Ngn3 þ non-b cells in PDL is not as high as initially claimed in Xu et al. 6 , even in PDL pancreas with strong Ngn3 gene induction.
We do find, however, that Ngn3 þ non-b cells are key to the in vivo expansion of b cells and generation of replication-prone b cells in injured adult pancreas. A mechanistic role for Ngn3 þ cell activation in b cell formation in PDL is supported by the correlation between Ngn3-transcript levels and the preponderance of Ngn3 þ cells on the one hand and the finding that b cell proliferation depends on Ngn3 þ cells on the other. Our findings provide a platform for characterization of the signals that control neogenesis and b cell proliferation in the adult pancreas and may be drug targets for regenerative treatment of diabetes.
Materials and Methods
Mouse manipulation. All mice experiments were performed according to the guidelines of our institutional 'Ethical Committee for Animal Experiments' and national guidelines and regulations. Pancreatic duct ligation or Sham operation were performed as described. 6, 10 Cell tracing. Mice were continuously labeled by administering CldU, IdU, in drinking water bottles at 1 mg/ml 3 . CldU (C6891) and IdU (347580) were obtained from Sigma Aldrich (Diegem, Belgium).
Tamoxifen (Sigma, T5648) was dissolved at 10 mg/ml in corn oil (Sigma, C8267). For PDL studies in adult mice, a total of 20 mg of tamoxifen (TAM) was given s.c. in five doses (each 4 mg) over a 2-week period. In Ngn3 CreERT ;R26 iDTR mice, diphtheria toxin was given (three tail vein injections of 125 ng each) during the last 3 days of the post-PDL period.
b cell volume and insulin content. The measurement of b cell volume (mm 3 ) in PDL or Sham tail pancreas was performed as described previously. 6 Analysis of each organ was based on a large number of 4 mm-sections equally spaced and spanning the whole tissue, together representing 10% of the total volume. Measurement of pancreas insulin content was done as described 26 as well as OPT 3D analysis. 16 
